Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Apr 15;97(8):1864–1873. doi: 10.1172/JCI118617

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

A C Crawley 1, D A Brooks 1, V J Muller 1, B A Petersen 1, E L Isaac 1, J Bielicki 1, B M King 1, C D Boulter 1, A J Moore 1, N L Fazzalari 1, D S Anson 1, S Byers 1, J J Hopwood 1
PMCID: PMC507255  PMID: 8621770

Abstract

We report studies that suggest enzyme replacement therapy will result in a significant reduction in disease progression and tissue pathology in patients with Maroteaux-Lamy syndrome (Mucopolysaccharidosis type VI, MPS VI). A feline model for MPS VI was used to evaluate tissue distribution and clinical efficacy of three forms of recombinant human N-acetylgalactosamine-4-sulfatase (rh4S, EC 3.1.6.1). Intravenously administered rh4S was rapidly cleared from circulation. The majority of rh4S was distributed to liver, but was also detected in most other tissues. Tissue half-life was approximately 2-4 d. Three MPS VI cats given regular intravenous infusions of rh4S for up to 20 mo showed variable reduction of storage vacuoles in Kupffer cells and connective tissues, however cartilage chondrocytes remained vacuolated. Vertebral bone mineral volume was improved in two MPS VI cats in which therapy was initiated before skeletal maturity, and increased bone volume appeared to correlate with earlier age of onset of therapy. One cat showed greater mobility in response to therapy.

Full Text

The Full Text of this article is available as a PDF (707.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amigorena S., Drake J. R., Webster P., Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature. 1994 May 12;369(6476):113–120. doi: 10.1038/369113a0. [DOI] [PubMed] [Google Scholar]
  2. Anson D. S., Taylor J. A., Bielicki J., Harper G. S., Peters C., Gibson G. J., Hopwood J. J. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J. 1992 Jun 15;284(Pt 3):789–794. doi: 10.1042/bj2840789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barton N. W., Furbish F. S., Murray G. J., Garfield M., Brady R. O. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1913–1916. doi: 10.1073/pnas.87.5.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bielicki J., Hopwood J. J., Wilson P. J., Anson D. S. Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem J. 1993 Jan 1;289(Pt 1):241–246. doi: 10.1042/bj2890241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Birkenmeier E. H., Barker J. E., Vogler C. A., Kyle J. W., Sly W. S., Gwynn B., Levy B., Pegors C. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood. 1991 Dec 1;78(11):3081–3092. [PubMed] [Google Scholar]
  6. Bou-Gharios G., Abraham D., Olsen I. Lysosomal storage diseases: mechanisms of enzyme replacement therapy. Histochem J. 1993 Sep;25(9):593–605. doi: 10.1007/BF00157873. [DOI] [PubMed] [Google Scholar]
  7. Brooks D. A., Gibson G. J., Hopwood J. J. Immunochemical characterization of feline and human N-acetylgalactosamine 4-sulfatase. Biochem Med Metab Biol. 1994 Oct;53(1):58–66. doi: 10.1006/bmmb.1994.1058. [DOI] [PubMed] [Google Scholar]
  8. Brooks D. A., McCourt P. A., Gibson G. J., Hopwood J. J. Immunoquantification of the low abundance lysosomal enzyme N-acetylgalactosamine 4-sulphatase. J Inherit Metab Dis. 1990;13(1):108–120. doi: 10.1007/BF01799338. [DOI] [PubMed] [Google Scholar]
  9. Cox K. O., Evans D., Brooks D., Cunliffe D. A. In vitro investigation of autoantibody-secreting peritoneal cells and their regulation. Immunology. 1979 Oct;38(2):355–365. [PMC free article] [PubMed] [Google Scholar]
  10. Field R. E., Buchanan J. A., Copplemans M. G., Aichroth P. M. Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development. J Bone Joint Surg Br. 1994 Nov;76(6):975–981. [PubMed] [Google Scholar]
  11. Furbish F. S., Steer C. J., Krett N. L., Barranger J. A. Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation. Biochim Biophys Acta. 1981 Apr 3;673(4):425–434. doi: 10.1016/0304-4165(81)90474-8. [DOI] [PubMed] [Google Scholar]
  12. Gibson G. J., Saccone G. T., Brooks D. A., Clements P. R., Hopwood J. J. Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochem J. 1987 Dec 15;248(3):755–764. doi: 10.1042/bj2480755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gold E. W. A simple spectrophotometric method for estimating glycosaminoglycan concentrations. Anal Biochem. 1979 Oct 15;99(1):183–188. doi: 10.1016/0003-2697(79)90061-7. [DOI] [PubMed] [Google Scholar]
  14. Haskins M. E., Aguirre G. D., Jezyk P. F., Patterson D. F. The pathology of the feline model of mucopolysaccharidosis VI. Am J Pathol. 1980 Dec;101(3):657–674. [PMC free article] [PubMed] [Google Scholar]
  15. Haskins M. E., Bingel S. A., Northington J. W., Newton C. D., Sande R. D., Jezyk P. F., Patterson D. F. Spinal cord compression and hindlimb paresis in cats with mucopolysaccharidosis VI. J Am Vet Med Assoc. 1983 May 1;182(9):983–985. [PubMed] [Google Scholar]
  16. Hopwood J. J., Harrison J. R. High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. Anal Biochem. 1982 Jan 1;119(1):120–127. doi: 10.1016/0003-2697(82)90674-1. [DOI] [PubMed] [Google Scholar]
  17. Hopwood J. J., Morris C. P. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med. 1990 Oct;7(5):381–404. [PubMed] [Google Scholar]
  18. Hopwood J. J., Vellodi A., Scott H. S., Morris C. P., Litjens T., Clements P. R., Brooks D. A., Cooper A., Wraith J. E. Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis. 1993;16(6):1024–1033. doi: 10.1007/BF00711520. [DOI] [PubMed] [Google Scholar]
  19. Jezyk P. F., Haskins M. E., Patterson D. F., Mellman W. J., Greenstein M. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science. 1977 Nov 25;198(4319):834–836. doi: 10.1126/science.144321. [DOI] [PubMed] [Google Scholar]
  20. Kampine J. P., Brady R. O., Kanfer J. N., Feld M., Shapiro D. Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood. Science. 1967 Jan 6;155(3758):86–88. doi: 10.1126/science.155.3758.86. [DOI] [PubMed] [Google Scholar]
  21. McGovern M. M., Ludman M. D., Short M. P., Steinfeld L., Kattan M., Raab E. L., Krivit W., Desnick R. J. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT. Birth Defects Orig Artic Ser. 1986;22(1):41–53. [PubMed] [Google Scholar]
  22. McGovern M. M., Vine D. T., Haskins M. E., Desnick R. J. Purification and properties of feline and human arylsulfatase B isozymes. Evidence for feline homodimeric and human monomeric structures. J Biol Chem. 1982 Nov 10;257(21):12605–12610. [PubMed] [Google Scholar]
  23. Navarro C., Dominguez C., Costa M., Ortega J. J. Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation. Acta Neuropathol. 1991;82(1):33–38. doi: 10.1007/BF00310920. [DOI] [PubMed] [Google Scholar]
  24. Norrdin R. W., Moffat K. S., Thrall M. A., Gasper P. W. Characterization of osteopenia in feline mucopolysaccharidosis VI and evaluation of bone marrow transplantation therapy. Bone. 1993 May-Jun;14(3):361–367. doi: 10.1016/8756-3282(93)90165-7. [DOI] [PubMed] [Google Scholar]
  25. Peters C., Schmidt B., Rommerskirch W., Rupp K., Zühlsdorf M., Vingron M., Meyer H. E., Pohlmann R., von Figura K. Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J Biol Chem. 1990 Feb 25;265(6):3374–3381. [PubMed] [Google Scholar]
  26. Sands M. S., Vogler C., Kyle J. W., Grubb J. H., Levy B., Galvin N., Sly W. S., Birkenmeier E. H. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J Clin Invest. 1994 Jun;93(6):2324–2331. doi: 10.1172/JCI117237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schuchman E. H., Jackson C. E., Desnick R. J. Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C. Genomics. 1990 Jan;6(1):149–158. doi: 10.1016/0888-7543(90)90460-c. [DOI] [PubMed] [Google Scholar]
  28. Shull R. M., Kakkis E. D., McEntee M. F., Kania S. A., Jonas A. J., Neufeld E. F. Enzyme replacement in a canine model of Hurler syndrome. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12937–12941. doi: 10.1073/pnas.91.26.12937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stanley P., Caillibot V., Siminovitch L. Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell. Cell. 1975 Oct;6(2):121–128. doi: 10.1016/0092-8674(75)90002-1. [DOI] [PubMed] [Google Scholar]
  30. Taylor J. A., Gibson G. J., Brooks D. A., Hopwood J. J. Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts. Biochem J. 1990 Jun 1;268(2):379–386. doi: 10.1042/bj2680379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tulp A., Verwoerd D., Dobberstein B., Ploegh H. L., Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature. 1994 May 12;369(6476):120–126. doi: 10.1038/369120a0. [DOI] [PubMed] [Google Scholar]
  32. Underwood J. R., Csar X. F., Veitch B. A., Hearn M. T. Characterization of the specificity of a naturally-occurring monoclonal anti-thymocyte autoantibody derived from an unimmunized, neonatal Balb/c mouse. Thymus. 1993 Jun;21(4):199–219. [PubMed] [Google Scholar]
  33. Van der Ploeg A. T., Kroos M. A., Willemsen R., Brons N. H., Reuser A. J. Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. J Clin Invest. 1991 Feb;87(2):513–518. doi: 10.1172/JCI115025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vogler C., Sands M., Higgins A., Levy B., Grubb J., Birkenmeier E. H., Sly W. S. Enzyme replacement with recombinant beta-glucuronidase in the newborn mucopolysaccharidosis type VII mouse. Pediatr Res. 1993 Dec;34(6):837–840. doi: 10.1203/00006450-199312000-00028. [DOI] [PubMed] [Google Scholar]
  35. Yoshida M., Noguchi J., Ikadai H., Takahashi M., Nagase S. Arylsulfatase B-deficient mucopolysaccharidosis in rats. J Clin Invest. 1993 Mar;91(3):1099–1104. doi: 10.1172/JCI116268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zöller M., Achtnich M. Evidence for regulation of naturally activated autoreactive B cells. Eur J Immunol. 1991 Feb;21(2):305–312. doi: 10.1002/eji.1830210210. [DOI] [PubMed] [Google Scholar]
  37. van de Kamp J. J., Niermeijer M. F., von Figura K., Giesberts M. A. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet. 1981 Aug;20(2):152–160. doi: 10.1111/j.1399-0004.1981.tb01821.x. [DOI] [PubMed] [Google Scholar]
  38. von Figura K., Hasilik A. Lysosomal enzymes and their receptors. Annu Rev Biochem. 1986;55:167–193. doi: 10.1146/annurev.bi.55.070186.001123. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES